Home › Funds › MOR Wealth Management, LLC › IBRX

MOR Wealth Management, LLC position in IBRX

IMMUNITYBIO INC · Health Care

MOR Wealth Management, LLC reported holding 302,447 shares of IBRX (IMMUNITYBIO INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 1.05% of its reported portfolio and ranking #20 among its reported holdings. MOR Wealth Management, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)302.45K sh
Reported value held$2.65M
Portfolio Weight1.05%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MOR Wealth Management, LLC's IBRX position evolved

MOR Wealth Management, LLC first disclosed a stake in IBRX in Q4 2025 at 249,265 shares (US$494K). The position peaked in Q2 2026 at 302,447 shares, worth US$2.6M. Across 3 filings, MOR Wealth Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 302,447 shares valued at US$2.6M — an increase of 19,200 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 249.26K $493.55K New
Q1 2026 283.25K $2.17M Add
Q2 2026 302.45K $2.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has MOR Wealth Management, LLC held IBRX?

MOR Wealth Management, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is MOR Wealth Management, LLC's current position in IBRX?

As of Q2 2026, MOR Wealth Management, LLC holds 302.45K shares of IBRX (IMMUNITYBIO INC), valued at $2.65M, representing 1.05% of its reported portfolio and ranking #20.

Has MOR Wealth Management, LLC been buying or selling IBRX?

In the latest 13F filing (Q2 2026), MOR Wealth Management, LLC increased its position in IBRX. The position peaked in Q2 2026 at 302.45K shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.